Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer

Clinical trial NCT00320749 · COMPLETED

Trial details

NCT number: NCT00320749
Sponsor: Tony Bekaii-Saab
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2005-12-01
Primary completion: 2008-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.